Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,243.46
-11.9450-0.95%
Volume:171.18K
Turnover:212.48M
Market Cap:1.18T
PE:41.74
High:1,262.14
Open:1,262.14
Low:1,230.98
Close:1,255.40
52wk High:1,292.65
52wk Low:694.23
Shares:945.38M
Float Shares:939.00M
Volume Ratio:1.84
T/O Rate:0.02%
Dividend:6.69
Dividend Rate:0.54%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:34.70
PE(LYR):54.18

Loading ...

Ataibeckley Inc: Co to Pay Eli Lilly Termination Fee of $104.3 Mln if Deal Terminated Under Some Circumstances - SEC Filing

THOMSON REUTERS
·
Jul 16

Eli Lilly Expands Neuroscience Footprint with Ataibeckley Acquisition

Dow Jones
·
Jul 16

Eli Lilly Says Milestone Payments Boost Potential Value of Ataibeckley Deal

Dow Jones
·
Jul 16

Eli Lilly Says Clinical Trial Success Propels Ataibeckley Lead Program into Phase 3

Dow Jones
·
Jul 16

Eli Lilly to Acquire AtaiBeckley for $2.8 Billion in Cash, Up to $1 Billion in Milestone Payments

MT Newswires Live
·
Jul 16

Ataibeckley Shares Pare Gains After Eli Lilly to Acquire Co for up to $3.8 Bln, Last up 31% Premarket

THOMSON REUTERS
·
Jul 16

Lilly to Buy Ataibeckley for USD 6.75 Per Share Plus CVR up to USD 2.5

Reuters
·
Jul 16

Eli Lilly - to Pay $6.75 Per Share Cash Plus up to $2.5 Per Share in CVR

THOMSON REUTERS
·
Jul 16

Eli Lilly - Voting Agreements Signed Covering 15% of Ataibeckley Shares

THOMSON REUTERS
·
Jul 16

Eli Lilly - Deal Valued at $2.8 Bln Upfront with up to $1 Bln in CVR

THOMSON REUTERS
·
Jul 16

Lilly to Acquire Ataibeckley to Advance Therapies for Treatment-resistant Depression and Other Mental Health Conditions

THOMSON REUTERS
·
Jul 16

Eli Lilly - Deal Expected to Close in Q3 Subject to Approvals

THOMSON REUTERS
·
Jul 16

Eli Lilly - Boards of Both Companies Approve Deal

THOMSON REUTERS
·
Jul 16

Eli Lilly: Will Determine Accounting Treatment of This Transaction in Accordance with Gaap upon Closing

THOMSON REUTERS
·
Jul 16

Market Chatter: Eli Lilly in Talks to Acquire AtaiBeckley

MT Newswires Live
·
Jul 16

Eli Lilly (LLY) Stock May Be Below Fair Value After FDA Cancer Drug Approval

Simply Wall St.
·
Jul 16

This Psychedelic Pharma Stock is Soaring 50% on Report of Eli Lilly Takeover Talks

Dow Jones
·
Jul 16

Ataibeckley Surges After Report Says Lilly is Nearing Buyout Deal

Reuters
·
Jul 16

Ataibeckley Shares Jump 42.2% Premarket After Report Eli Lilly Nears Deal to Buy Co

THOMSON REUTERS
·
Jul 16

AI is So Big, It's Now Impossible for Investors to Avoid

Dow Jones
·
Jul 16